|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Investments: | ||||||||||||||||
| Fixed maturity securities: | ||||||||||||||||
| Bonds available-for-sale, at fair value, net of allowance for credit losses of $— in 2026 and $130 in 2025 (amortized cost: 2026 - $—; 2025 - $203,848) | ||||||||||||||||
| Other bond securities, at fair value | ||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||
| Mortgage and other loans receivable, net of allowance for credit losses of $— in 2026 and $727 in 2025 | ||||||||||||||||
| Other invested assets (portion measured at fair value: 2026 - $—; 2025 - $8,106) | ||||||||||||||||
| Short-term investments, including restricted cash of $— in 2026 and $4 in 2025 (portion measured at fair value: 2026 - $—; 2025 - $1,624) | ||||||||||||||||
| Total investments | ||||||||||||||||
| Cash | ||||||||||||||||
| Accrued investment income | ||||||||||||||||
| Premiums and other receivables, net of allowance for credit losses and disputes of $1 in 2026 and $1 in 2025 | ||||||||||||||||
| Reinsurance assets, net of allowance for credit losses and disputes | ||||||||||||||||
| Fortitude RE | ||||||||||||||||
| Excluding Fortitude | ||||||||||||||||
| Total reinsurance assets, net of allowance for credit losses and disputes | ||||||||||||||||
| Deferred income taxes | ||||||||||||||||
| Current and deferred income taxes | ||||||||||||||||
| Deferred policy acquisition costs and value of business acquired | ||||||||||||||||
| Market risk benefit assets, at fair value | ||||||||||||||||
| Other assets, including restricted cash of $— in 2026 and $2 in 2025 (portion measured at fair value: 2026 - $—; 2025 - $441) | ||||||||||||||||
| Separate account assets, at fair value | ||||||||||||||||
| Assets held-for-sale | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities: | ||||||||||||||||
| Future policy benefits for life and accident and health insurance contracts | ||||||||||||||||
| Policyholder contract deposits (portion measured at fair value: 2026 - $13,568; 2025 - $12,156) | ||||||||||||||||
| Market risk benefit liabilities, at fair value | ||||||||||||||||
| Other policyholder funds | ||||||||||||||||
| Fortitude Re funds withheld payable (portion measured at fair value: 2026 - $3,971; 2025 - $3,795) | ||||||||||||||||
| Other liabilities (portion measured at fair value: 2026 - $—; 2025 - $322) | ||||||||||||||||
| Short-term debt | ||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | ||||||||||||||||
| Total short-term debt | ||||||||||||||||
| Short-term and long-term debt, of which $1,250 in 2026 and $0 in 2025 is short-term debt | ||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | ||||||||||||||||
| Debt of consolidated investment entities | ||||||||||||||||
| Total short-term and long-term debt, of which $1,250 in 2026 and $0 in 2025 is short-term debt | ||||||||||||||||
| Debt of consolidated investment entities | ||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | ||||||||||||||||
| Debt of consolidated investment entities | ||||||||||||||||
| Separate account liabilities | ||||||||||||||||
| Liabilities held-for-sale | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Corebridge Shareholders' equity: | ||||||||||||||||
| Common stock, $0.01 par value; 2,500,000,000 shares authorized; shares issued: 2024 - 650,189,849 and 2023 648,148,737 | ||||||||||||||||
| Preferred stock and additional paid-in capital, $1 par value and $1,000 liquidation preference | ||||||||||||||||
| Common stock, $0.01 par value; 2,500,000,000 shares authorized; shares issued: 2026 - 650,189,849 and 2025 - 650,189,849 | ||||||||||||||||
| Treasury stock, at cost; 2026 - 204,421,241 shares and 2025 - 153,816,103 shares | ||||||||||||||||
| Additional paid-in capital | ||||||||||||||||
| Retained earnings | ||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||
| Total Corebridge Shareholders' equity | ||||||||||||||||
| Non-redeemable noncontrolling interests | ||||||||||||||||
| Total equity | ||||||||||||||||
| Total liabilities and equity | ||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||
| Total common stock, shares issued (in shares) | ||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||
| Total common stock, par value (in dollars per share) | ||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||
| Total common stock, shares authorized (in shares) | ||||||||||||||||
Loading...
